SelectQuote Inc

SelectQuote Inc(SLQT)の株式分析

$0.390

-0.080 (-20.61%)終値時点

Loading chart…
高値
0.496
始値
0.484
出来高加重平均価格
0.42
出来高
2.03M
時価総額
463.49M
安値
0.360
売買代金
844.31K
EV/EBITDA(TTM)
3.64

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

AI分析 of SelectQuote Inc (SLQT)

買い

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

バリュエーション指標

SelectQuote Inc(SLQT)の現在の予想PERは66.67で、5年平均は2.48です。

予想PER

割高
5年平均 P/E
2.48
現在のP/E
66.67
割高
48.70
割安
-43.74

予想EV/EBITDA

適正
5年平均 EV/EBITDA
1.71
現在のEV/EBITDA
3.64
割高
54.04
割安
-50.62

予想PSR

適正
5年平均 P/S
0.29
現在のP/S
0.06
割高
0.56
割安
0.03

Alphio AI による SLQT の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%SLQT

$2.27

シナリオ価格

基

基本

基本 · 50%SLQT

$2.16

シナリオ価格

弱

弱気

弱気 · 25%SLQT

$1.66

シナリオ価格

SLQT を保有するクジラ

A

Abrams Bison Investments, L.L.C.

+ を保有SLQT

+8.79%

3か月リターン

イベントタイムライン

2026-11-04 (ET)

07:30:00

SelectQuote Reports Q1 Revenue of $280M

07:30:00

Sees FY27 Adjusted EBITDA of $90M-$115M

2026-08-25 (ET)

16:30:00

Major Averages Rise as Chip Stocks Benefit from Nvidia Earnings

12:30:00

Major Averages Slightly Higher, Chip Stocks Benefit from Nvidia Earnings

07:30:00

Sees FY27 Adjusted EBITDA at $90M-$115M

ニュース

SLQT のよくある質問 — Alphio AI が回答

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy. It operates in the Financials sector (INSURANCE AGENTS, BROKERS & SERVICE industry).

SelectQuote Inc (SLQT) appears to be a good buy right now due to its recent price momentum and favorable valuation metrics. The current price is $0.402, which is significantly below its 52-week high of $2.17, indicating potential for recovery. The stock has shown a 5-day change of +22.90%, reflecting strong short-term performance. Additionally, the forward P/E ratio is 66.67, suggesting that while the stock is expensive based on earnings, it is trading at a low price-to-sales ratio of 0.0395, indicating it may be undervalued relative to its sales. However, the main risk is the negative earnings per share (EPS) estimate of -0.26 for the upcoming quarter, which could lead to further volatility.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める